Literature DB >> 10824054

Extensive psoriasis induced by interferon alfa treatment for chronic hepatitis C.

C Taylor1, D A Burns, M J Wiselka.   

Abstract

A 47 year old man with chronic hepatitis C was treated with interferon alfa, 3 million units three times a week, and developed widespread plaque psoriasis within weeks of starting interferon therapy. There was no previous history of psoriasis. The psoriasis was characterised by extensive nail involvement and plaques at the interferon injection sites. The patient relapsed after a total of 12 months of interferon and was subsequently treated with interferon and tribavirin (ribavirin) with recurrence of the psoriasis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10824054      PMCID: PMC1741616          DOI: 10.1136/pmj.76.896.365

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  11 in total

1.  [Drug-induced exanthema caused by pegylated interferon-alpha 2b].

Authors:  S Meller; A Erhardt; A Auci; N J Neumann; B Homey
Journal:  Hautarzt       Date:  2003-10       Impact factor: 0.751

Review 2.  Induction and exacerbation of psoriasis with Interferon-alpha therapy for hepatitis C: a review and analysis of 36 cases.

Authors:  M Afshar; A D Martinez; R L Gallo; T R Hata
Journal:  J Eur Acad Dermatol Venereol       Date:  2012-06-01       Impact factor: 6.166

3.  [Sarcoidosis induced by therapy with pegylated interferon alfa-2a].

Authors:  D Bruch-Gerharz; J Reifenberger
Journal:  Hautarzt       Date:  2006-04       Impact factor: 0.751

4.  Paradoxical psoriasiform reactions to anti-TNFα drugs are associated with genetic polymorphisms in patients with psoriasis.

Authors:  T Cabaleiro; R Prieto-Pérez; R Navarro; G Solano; M Román; D Ochoa; F Abad-Santos; E Daudén
Journal:  Pharmacogenomics J       Date:  2015-07-21       Impact factor: 3.550

Review 5.  A review of adverse cutaneous drug reactions resulting from the use of interferon and ribavirin.

Authors:  Nisha Mistry; Jonathan Shapero; Richard I Crawford
Journal:  Can J Gastroenterol       Date:  2009-10       Impact factor: 3.522

6.  Learning the lessons of antitumour necrosis factor therapy-associated psoriasis.

Authors:  Matt Shale; Subrata Ghosh
Journal:  Can J Gastroenterol       Date:  2009-10       Impact factor: 3.522

7.  Psoriasis and hepatitis C: improvement with interferon.

Authors:  Eyassu Habte-Gabr; Nicolas Lecea
Journal:  Ann Dermatol       Date:  2011-12-27       Impact factor: 1.444

8.  Extensive psoriasis induced by pegylated interferon: a case report.

Authors:  Vincenzo Citro; Raffaele Fristachi; Giovanni Tarantino
Journal:  J Med Case Rep       Date:  2007-09-17

9.  Extensive psoriasis induced by pegylated interferon alfa-2a and ribavirin in the treatment of chronic hepatitis C.

Authors:  Gun-Wook Kim; Seung-Wook Jwa; Margaret Song; Hoon-Soo Kim; Byung-Soo Kim; Moon-Bum Kim; Hyun-Chang Ko
Journal:  Ann Dermatol       Date:  2013-11-30       Impact factor: 1.444

10.  Exacerbation of Skin Lesions in a 50 year old Man with Psoriasis during Treatment by Pegylated Interferon.

Authors:  Amir Houshang Sharifi; Elham Fakharzadeh; Hedyeh Zamini; Arghavan Haj-Sheykholeslami; Hossain Jabbari
Journal:  Middle East J Dig Dis       Date:  2012-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.